Chemcrux Enterprises Limited (BOM:540395)
India · Delayed Price · Currency is INR 103.46
-3.25 (-3.05%)
At close: Feb 12, 2026
Chemcrux Enterprises Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 720.86 | 700.1 | 784.65 | 951.52 | 952.71 | 533.31 |
Other Revenue | 6.57 | 6.57 | 3.53 | - | - | - |
| 727.43 | 706.67 | 788.19 | 951.52 | 952.71 | 533.31 | |
Revenue Growth (YoY) | -0.11% | -10.34% | -17.17% | -0.12% | 78.64% | -7.17% |
Cost of Revenue | 293.13 | 286.1 | 324.54 | 437.64 | 502.04 | 223.72 |
Gross Profit | 434.31 | 420.57 | 463.65 | 513.89 | 450.66 | 309.59 |
Selling, General & Admin | 92.96 | 86.36 | 88.92 | 79.66 | 63.37 | 61.38 |
Other Operating Expenses | 241.86 | 233.02 | 234.81 | 218.54 | 176.28 | 118.23 |
Operating Expenses | 380.31 | 351.44 | 346.57 | 318.57 | 255.53 | 191.62 |
Operating Income | 53.99 | 69.13 | 117.07 | 195.32 | 195.14 | 117.98 |
Interest Expense | -31.28 | -17.38 | -6.47 | -4.55 | -1.38 | -1.39 |
Interest & Investment Income | 0.47 | 0.47 | 0.38 | 2.88 | 0.92 | 0.75 |
Earnings From Equity Investments | - | -0.05 | - | - | - | - |
Currency Exchange Gain (Loss) | 1.88 | 1.88 | 2.13 | 1.92 | 2.26 | 1.3 |
Other Non Operating Income (Expenses) | 4.73 | 0.57 | -0.55 | -3.05 | 0.05 | -0.1 |
EBT Excluding Unusual Items | 29.8 | 54.63 | 112.56 | 192.51 | 196.98 | 118.54 |
Gain (Loss) on Sale of Investments | 2.38 | 2.38 | 3.44 | 3.8 | 2.11 | 1.45 |
Gain (Loss) on Sale of Assets | 0.6 | 0.6 | - | 0.17 | 0.39 | - |
Asset Writedown | - | - | -1.68 | - | - | - |
Pretax Income | 32.78 | 57.61 | 114.32 | 196.48 | 199.48 | 119.99 |
Income Tax Expense | 11.92 | 18.47 | 29.87 | 52.9 | 50.89 | 30.66 |
Net Income | 20.85 | 39.13 | 84.44 | 143.58 | 148.59 | 89.34 |
Net Income to Common | 20.85 | 39.13 | 84.44 | 143.58 | 148.59 | 89.34 |
Net Income Growth | -62.85% | -53.66% | -41.19% | -3.37% | 66.32% | -16.06% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | -0.07% | - | - | - | 0.00% | - |
EPS (Basic) | 1.41 | 2.64 | 5.70 | 9.70 | 10.03 | 6.03 |
EPS (Diluted) | 1.41 | 2.64 | 5.70 | 9.70 | 10.03 | 6.03 |
EPS Growth | -62.87% | -53.68% | -41.21% | -3.33% | 66.26% | -16.06% |
Free Cash Flow | - | -8.03 | -79.46 | 36.51 | 45.57 | 30.39 |
Free Cash Flow Per Share | - | -0.54 | -5.37 | 2.47 | 3.08 | 2.05 |
Dividend Per Share | - | 1.000 | 1.000 | 2.000 | 2.000 | 0.667 |
Dividend Growth | - | - | -50.00% | - | 199.98% | -50.00% |
Gross Margin | 59.70% | 59.51% | 58.82% | 54.01% | 47.30% | 58.05% |
Operating Margin | 7.42% | 9.78% | 14.85% | 20.53% | 20.48% | 22.12% |
Profit Margin | 2.87% | 5.54% | 10.71% | 15.09% | 15.60% | 16.75% |
Free Cash Flow Margin | - | -1.14% | -10.08% | 3.84% | 4.78% | 5.70% |
EBITDA | 91.69 | 99.93 | 138.68 | 214.41 | 209.66 | 129.99 |
EBITDA Margin | 12.60% | 14.14% | 17.59% | 22.53% | 22.01% | 24.37% |
D&A For EBITDA | 37.69 | 30.8 | 21.61 | 19.1 | 14.53 | 12.01 |
EBIT | 53.99 | 69.13 | 117.07 | 195.32 | 195.14 | 117.98 |
EBIT Margin | 7.42% | 9.78% | 14.85% | 20.53% | 20.48% | 22.12% |
Effective Tax Rate | 36.38% | 32.07% | 26.13% | 26.92% | 25.51% | 25.55% |
Revenue as Reported | 739.89 | 714.97 | 798.01 | 962.05 | 962.69 | 541.27 |
Advertising Expenses | - | 0.72 | 0.63 | 0.53 | 0.2 | 0.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.